Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Araris Biotech, a Switzerland-based biotech spinout of Paul Scherrer Institute, part of the Domain of the Swiss Federal Institutes of Technology (ETH Domain) system, closed an oversubscribed CHF2.5m ($2.5m) seed round today with participation from Redalpine, Schroder Adveq and VI Partners. The cash will allow Araris to develop a pipeline of site-specific antibody-drug conjugates to treat diseases including cancer. The spinout was formed in March 2019.
Riptron, a UK-based graphene sensor technology spinout of University of Manchester, secured…
